-+ 0.00%
-+ 0.00%
-+ 0.00%

Access Bio Signs USD 3.73 Million Contract to Supply Flu, COVID-19 Home Tests to P&G Subsidiary

PUBT·10/20/2026 05:07:07
Access Bio Signs USD 3.73 Million Contract to Supply Flu, COVID-19 Home Tests to P&G Subsidiary
  • Access Bio signed a KRW 4.97 billion supply contract with Procter & Gamble Manufacturing on October 20, 2026.
  • The deal covers Flu A, Flu B and COVID-19 combination home tests for the US market.
  • The contract value represents 15.89% of 2025 consolidated revenue.
  • Supply runs from October 15, 2026, through October 14, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Access Bio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261020900298), on October 20, 2026, and is solely responsible for the information contained therein.